{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:12:49Z","timestamp":1769580769495,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jasc.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T12:39:01Z","timestamp":1597322341000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0584-1557","authenticated-orcid":false,"given":"Daria","family":"Vasilyeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Tiscornia-Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel A.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/LGT.0000000000000322","article-title":"Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States","volume":"21","author":"Wentzensen","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/pubmed\/fdt057","article-title":"Co-testing for detection of high-grade cervical intraepithelial neoplasia and cancer compared with cytology alone: a meta-analysis of randomized controlled trials","volume":"36","author":"Bouchard-Fortier","year":"2014","journal-title":"J Public Health"},{"key":"10.1016\/j.jasc.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines Committee (2020). 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejogrb.2013.01.012","article-title":"Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy","volume":"168","author":"Sammarco","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jasc.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Suppl 1","key":"10.1016\/j.jasc.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","article-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/1471-0528.14627","article-title":"Is extending screening intervals safe in human papillomavirus-negative women?","volume":"124","author":"Kitchener","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jasc.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cncy.21557","article-title":"Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory","volume":"123","author":"Zheng","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5858\/arpa.2014-0028-OA","article-title":"Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study","volume":"139","author":"Zhao","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cncy.21545","article-title":"History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China","volume":"123","author":"Tao","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejca.2007.12.002","article-title":"Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3","volume":"44","author":"Kotaniemi-Talonen","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/ijc.29143","article-title":"Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection","volume":"136","author":"Gage","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ygyno.2014.03.008","article-title":"Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China","volume":"133","author":"Pan","year":"2014","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.jasc.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s12879-019-4614-y","article-title":"Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China\u2019s largest independent operator of pathology laboratories","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jasc.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncy.21687","article-title":"Clinical performance of the Food and Drug Administration-approved high-risk HPV test for the detection of high-grade cervicovaginal lesions","volume":"124","author":"Zhou","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jasc.2018.07.003","article-title":"HPV screening, invasive cervical cancer and screening policy in Australia","volume":"7","author":"Cox","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib24","doi-asserted-by":"crossref","first-page":"e1002666","DOI":"10.1371\/journal.pmed.1002666","article-title":"High-risk human papillomavirus status and prognosis in invasive cervical cancer: a nationwide cohort study","volume":"15","author":"Lei","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jasc.2020.08.006_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jasc.2019.03.005","article-title":"The impact of primary HPV screening on the incidence of cervical cancer in New Zealand","volume":"2019","author":"Cox","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis","volume":"122","author":"Rodr\u00edguez-Carunchio","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jasc.2020.08.006_bib27","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.18632\/oncotarget.14533","article-title":"Identification and characterization of HPV-independent cervical cancers","volume":"8","author":"Banister","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jasc.2020.08.006_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jasc.2018.01.003","article-title":"The effects of the Bethesda System 2014 on endometrial cell reporting and follow-up endometrial biopsies in women 45 years of age and over","volume":"7","author":"Moyer","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.5858\/arpa.2016-0356-RA","article-title":"Cervical adenocarcinoma: diagnosis of human papillomavirus-positive and human papillomavirus-negative tumors","volume":"141","author":"Pirog","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.08.006_bib30","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3389\/fmicb.2018.02896","article-title":"Involvement of human papillomaviruses in cervical cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jasc.2020.08.006_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.08.006_bib32","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study","volume":"137","author":"Holl","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.08.006_bib34","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases","volume":"27","author":"Pirog","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib35","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/ijc.30401","article-title":"The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: a hospital based nation-wide multi-center retrospective study across China","volume":"139","author":"Chen","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma","volume":"157","author":"Pirog","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cncy.21622","article-title":"Why follow-back studies should be interpreted cautiously: the case of an HPV-negative cervical lesion","volume":"124","author":"Giorgi Rossi","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pvr.2017.10.003","article-title":"Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers","volume":"4","author":"Petry","year":"2017","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.jasc.2020.08.006_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijgo.12030","article-title":"Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2\/3 or cervical cancer","volume":"136","author":"Gonz\u00e1lez-Bosquet","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jasc.2020.08.006_bib40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/cncy.21914","article-title":"Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital","volume":"125","author":"Tao","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0b013e3182909f86","article-title":"Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV test","volume":"18","author":"Igidbashian","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.08.006_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1309\/QEJBYT77YMTEVJ66","article-title":"Characteristics of apparently false-negative Digene Hybrid Capture 2 high-risk HPV DNA testing","volume":"125","author":"Jastania","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ijc.1455","article-title":"Hybrid Capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples","volume":"94","author":"Yamazaki","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cncr.22688","article-title":"Significance and possible causes of false-negative results of reflex human papillomavirus infection testing","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.08.006_bib44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cncy.21905","article-title":"Discrepant HPV\/cytology cotesting results: are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?","volume":"125","author":"Tracht","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib45","doi-asserted-by":"crossref","first-page":"e0220373","DOI":"10.1371\/journal.pone.0220373","article-title":"Pitfalls of commercially available HPV tests in HPV68a detection","volume":"14","author":"Jaworek","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2020.08.006_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/DHPS.S37273","article-title":"Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening","volume":"4","author":"Naryshkin","year":"2012","journal-title":"Drug Healthcare Patient Saf"},{"key":"10.1016\/j.jasc.2020.08.006_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jasc.2014.01.001","article-title":"Human papillomavirus testing in patients with invasive cervical carcinoma: an institutional experience","volume":"3","author":"Can","year":"2014","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.08.006_bib49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jasc.2018.08.002","article-title":"Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs","volume":"7","author":"Smith","year":"2018","journal-title":"J Am Soc Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520302714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520302714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:32Z","timestamp":1761979592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520302714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213294520302714"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.08.006","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society of Cytopathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}